Philip Barter (Heart Research Institute, Sydney, Australia),
HDL effects on vascular inflammation
Martin Bennett (Addenbrooke’s Hospital, Cambridge, UK),
Smooth muscle cell apoptosis in the vessel wall
Julie Campbell (Centre for Research in Vascular Biology, Brisbane, Australia),
New developments in artificial vascular grafts
Myron Cybulsky (Toronto General Research Institute & University of Toronto, Canada), Leukocytes, inflammation and the initiation of atherosclerosis
Mat Daemen (University of Maastricht, Netherlands), Gene expression profiling and immunomodulation in atherosclerosis
Françoise Dignat-George (INSERM, France), Endothelial progenitors and circulating endothelial cells: regeneration versus degeneration
Guillermo Garcia-Cardena (Harvard Medical School, Boston, USA), Endothelial vasoprotection
Anand Gautam (Progen Pharmaceuticals, Brisbane, Australia), Novel heparin-sulphate mimetics as inhibitors of tumor angiogenesis
Adriana C. Gittenberger-de Groot (Leiden University Medical Center, The Netherlands), Cardiovascular developmental biology
Arjan Griffioen (University Hospital Maastricht, The Netherlands), Tumour angiogenesis and the immune system
Avrum Gotlieb (University of Toronto, Canada)
Richard P. Harvey (Victor Chang Cardiac Research Institute, Sydney, Australia) Transcriptional networks in cardiac development and endogenous cardiac stem cells
Timothy Hla (University of Connecticut, USA), Regulation of vascular phenotype by sphingosine 1-phosphate signalling
Luisa Iruela-Arispe (UCLA, USA), Proteases and the ECM
Silviu Itescu (Columbia University, New York, USA), Cardiac stem cell therapy
David Kaye (Baker Heart Research Institute, Melbourne, Australia), Arginine transporters and hypertension
Bronwyn Kingwell (Baker Heart Research Institute, Melbourne, Australia), Metabolic effects of HDL
Leonard Kritharides (Centre for Vascular Research, Sydney)
Masahiko Kurabayashi (Gunma University Graduate School of Medicine, Japan), Role of Notch signaling in vascular calcification
B. Lowell Langille (MaRS Centre, Univ Toronto, Canada), Planar polarity of vascular cells in response to mechanical forces and injury
Bodo Levkau (University of Essen, Germany), Novel roles of HDL and HDL-associated sphingolipids in myocardial injury and atherosclerosis
Pek Lum (Rosetta Inpharmatics & Merck, Seattle, USA), Genetics and genomics of atherosclerosis in mice and man
William (Bill) Luscinskas (Harvard Medical School, Boston, USA), Adhesion Dependent Signaling During Leukocyte Transmigration
Nigel Mackman (University of North Carolina, Chapel Hill, USA), Tissue factor, a pivotal effector in haemostasis and vascular development
Mark Majesky (University of North Carolina, USA)
Zaid Mallat (INSERM, Paris, France), Regulatory T cell immunity in atherosclerosis
Manuel Mayr (Kings College London, UK), Proteomics-based development of biomarkers in cardiovascular disease
Ikuo Morita (Tokyo Medical and Dental University, Japan)
Andrew Newby (University of Bristol, UK), Foam cell phenotypes in vulnerable atherosclerotic plaques
Gary K. Owens (University of Virginia School of Medicine, USA), Epigenetic regulation of SMC lineage and phenotypic switching
Christopher Parish (John Curtin School of Medical Research, Canberra, Australia), Heparan sulfate mimetics as novel inhibitors in cancer
Gerard Pasterkamp (Utrecht Medical Center, Netherlands), Biomarkers of vulnerable plaque
Karlheinz Peter (Baker Heart Research Institute, Melbourne, Australia), Therapeutic integrin blockade in thrombosis and inflammation
Brian Petrich (UCSD, USA), Integrin signaling in vivo
Yasufumi Sato (Tohoku University, Japan), Vasohibin, an endogenous endothelial inhibitor of angiogenesis
Ann Marie Schmidt (Columbia University, New York, USA), RAGE: the complications of diabetes and the inflammatory response
Jan Schnitzer (Sidney Kimmel Cancer Center, San Diego, USA), Dynamic imaging, organellar proteomics and transendothelial delivery in vivo
Martin A. Schwartz (University of Virginia, USA), Integrins and extracellular matrix in endothelial responses to fluid shear stress
Stephen Schwartz (University of Washington, Seattle, USA), Do monocytes report the atherosclerotic plaque?
Alex Seifalian (University College London, UK), Development of cardiovascular bypass graft with nanocomposite materials and stem cell technology
Masabumi Shibuya (Tokyo Medical and Dental University, Japan)
Steven Stacker (Ludwig Institute for Cancer Research, Melbourne, Australia), VEGFs and lymphangiogenesis
Roland Stocker (Centre for Vascular Research, Sydney, Australia), Heme oxygenases and ROS
Nobuyuki Takakura (Osaka University, Japan), Maturation of blood vessels by hematopoietic stem cells
Jean-Claude Tardif (Montreal Heart Institute, Canada), Reconstituted HDL and coronary atherosclerosis
Victor van Hinsbergh (VU University Medical Center, Amsterdam, The Netherlands), Rho, ROCK and endothelial regulation of barrier function
George Yancopoulos (Regeneron, New York, USA), The VEGF Trap, Resistance to anti-VEGF Therapies, and the Delta Paradox
IVBM 2008 gratefully acknowledges support from EVBO and ISTH2005 Ltd
